Genotype–Phenotype Spectrum of 52 Mexican Patients With Fabry Disease: A Novel GLA Variant With Atypical Phenotype
Molecular Genetics & Genomic Medicine · 2024
DOI: 10.1002/mgg3.70039 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Genetics & Genomic Medicine, 2024. Verfasst von Tamara N Kimball und 5 weiteren Autor:innen. Beteiligte Einrichtung: División de Estudios de Posgrado de la Facultad de Medicina, Universidad Nacional Autónoma de, Mexico City, Mexico. Hauptthemen laut MEDLINE: Fabry Disease, alpha-Galactosidase, Phenotype. Die Arbeit nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Introduction
Fabry disease (FD) is a rare lysosomal type 3 disorder with an X‐linked inheritance pattern caused by pathogenic variants in the GLA gene. This study aimed to describe the genotype and phenotype of 52 Mexican patients with FD.
Methods
We included 12 patients with clinical and molecular diagnosis of FD treated at our institution and 40 FD Mexican patients already reported in the literature.
Results
The most frequent manifestations were acroparesthesias (71.2%), hypohidrosis or anhidrosis (48.1%), heat intolerance (46.2%), and proteinuria (42.3%). Renal and neurological manifestations were more prevalent in males than females. Cardiac involvement included hypertrophic cardiomyopathy and Wolf–Parkinson–White arrhythmia. Cornea verticillata was seen in 14 patients (26.9%) and angiokeratomas in 15 (28.8%). We identified 14 variants in the GLA gene in Mexican patients with FD. We found a novel variant GLA c.122C>G that causes an atypical FD phenotype with predominantly neurological involvement in two unrelated patients, one of them with a forthright clinical and radiological overlap of Multiple Sclerosis and normal biological biomarkers, thus requiring a renal biopsy that helped confirm the diagnosis of FD.
Conclusions
The genotype and phenotype of Mexican patients with FD are similar to other populations. Atypical phenotype of FD, such as the one associated with the novel variant c.122C>G, can be a diagnostic challenge, as it can be mixed up with MS. Our findings confirm the limitations of noninvasive diagnostic methods and the necessity of the renal biopsy when the clinical suspicion of FD is high.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- División de Estudios de Posgrado de la Facultad de Medicina, Universidad Nacional Autónoma de, Mexico City, Mexico.
- Departamento de Genética, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico.
- Departmento de Nefrología, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico.
- Tecnologico de Monterrey, Escuela de Medicina y Ciencias de la Salud, Mexico City, Mexico.
- Departmento de Patología, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico.
ORCID-Profile: Tamara N Kimball, Pamela Rivero-García, Eduardo R Argaiz, Jorge Eduardo Gaytan-Arocha, Norma Ofelia Uribe Uribe, Juan José Morales Suárez
Zitieren
APA
Kimball, T. N., Rivero-García, P., Argaiz, E. R., Gaytan-Arocha, J. E., Uribe, N. O. U., & Suárez, J. J. M. (2024). Genotype–Phenotype Spectrum of 52 Mexican Patients With Fabry Disease: A Novel GLA Variant With Atypical Phenotype. Molecular Genetics & Genomic Medicine. https://doi.org/10.1002/mgg3.70039
Vancouver
Kimball TN, Rivero-García P, Argaiz ER, Gaytan-Arocha JE, Uribe NOU, Suárez JJM. Genotype–Phenotype Spectrum of 52 Mexican Patients With Fabry Disease: A Novel GLA Variant With Atypical Phenotype. Molecular Genetics & Genomic Medicine. 2024. doi:10.1002/mgg3.70039
BibTeX
@article{Kimball2024,
author = {Kimball, Tamara N and Rivero-García, Pamela and Argaiz, Eduardo R and Gaytan-Arocha, Jorge Eduardo and Uribe, Norma Ofelia Uribe and Suárez, Juan José Morales},
title = {Genotype–Phenotype Spectrum of 52 Mexican Patients With Fabry Disease: A Novel GLA Variant With Atypical Phenotype},
journal = {Molecular Genetics & Genomic Medicine},
year = {2024},
doi = {10.1002/mgg3.70039}
}
EUVIMED